Patents/Assignees

Symberix, Inc.

1 patent in portfolio

US12017994utility2024
Compounds, Compositions, and Methods for Selectively Inhibiting Β-glucuronidases and Alleviating Side Effects Associated with Drug Treatment Induced Diarrhea
0 cites